Skip to main content
. 2020 Nov 16;36(6):1342–1352. doi: 10.1002/mds.28392

FIG. 2.

FIG. 2

Pantothenate Kinase–Associated Neurodegeneration‐Activities of Daily Living (PKAN‐ADL) total score change from baseline at week 24 in all patients (A), pediatric patients (B), and adult patients (C). Primary endpoint analysis (double‐blind period full analysis set). BL, baseline; CI, confidence interval; LS, least square; SE, standard error. [Color figure can be viewed at wileyonlinelibrary.com]